drugset / Trial / NCT01149499

Valacyclovir 1000 mg Tablet Under Fasting Conditions

NCT01149499

Phase 1 Completed 60 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-label

Summary

The objective of this study is to compare the rate and extent of absorption of valacyclovir 1000 mg tablet (test) versus Valtrex (reference), administered as 1 x 1000 mg tablet under fasting conditions.

Timeline

Start
2005-01
Primary completion
2005-01
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Valacyclovir Unknown 1000 mg

Indications

No indication recorded.